retavase

Frequently asked questions

What does Retavase treat?

Retavase (Reteplase) may be used to treat myocardial infarction, ventricular dysfunction, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.

Is there a coupon or discount for Retavase?

pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Retavase. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.

Who makes Retavase?

Retavase is marketed by Ekr Therap. You can see Ekr Therap's full profile, rating, and other products on pharmaranks.

Is Retavase a brand-name or generic drug?

Retavase is a brand-name product with the active ingredient Reteplase.

Is Retavase available over the counter?

No. Retavase is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.

What forms does Retavase come in?

Retavase is currently marketed as injectable, per the FDA's National Drug Code Directory.

Is Retavase FDA-registered?

Retavase is on record with the U.S. FDA under application number BLA103786. You can verify this on its official FDA label.